Celularity Inc. (CELU) DCF Valuation

Celularity Inc. (CELU) DCF Valuation
  • ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
  • ✓ Professional Design: Trusted, Industry-Standard Templates
  • ✓ Pre-Built For Quick And Efficient Use
  • ✓ No Expertise Is Needed; Easy To Follow

Celularity Inc. (CELU) Bundle

DCF model
Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Gain mastery over your Celularity Inc. (CELU) valuation analysis with our cutting-edge DCF Calculator! Preloaded with real CELU data, this Excel template enables you to adjust forecasts and assumptions to accurately compute the intrinsic value of Celularity Inc.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue 21.1 14.3 21.3 18.0 22.8 24.4 26.1 27.9 29.8 31.9
Revenue Growth, % 0 -32.48 49.43 -15.75 26.68 6.97 6.97 6.97 6.97 6.97
EBITDA -1.7 -202.4 -88.1 23.6 -183.9 -10.1 -10.8 -11.6 -12.4 -13.3
EBITDA, % -7.96 -1417.6 -412.98 131.19 -807.81 -41.59 -41.59 -41.59 -41.59 -41.59
Depreciation 6.2 8.2 8.8 9.4 9.3 10.8 11.5 12.3 13.2 14.1
Depreciation, % 29.25 57.25 41.33 52.17 40.95 44.19 44.19 44.19 44.19 44.19
EBIT -7.9 -210.6 -96.9 14.2 -193.3 -12.6 -13.5 -14.4 -15.4 -16.5
EBIT, % -37.21 -1474.85 -454.31 79.03 -848.75 -51.64 -51.64 -51.64 -51.64 -51.64
Total Cash .9 54.3 37.2 14.0 .2 13.8 14.7 15.8 16.9 18.1
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables .0 6.6 5.2 7.0 12.1
Account Receivables, % 0 45.87 24.53 38.75 53.22
Inventories 3.2 3.9 9.5 5.3 5.8 6.9 7.4 7.9 8.5 9.0
Inventories, % 15.28 26.96 44.76 29.53 25.26 28.36 28.36 28.36 28.36 28.36
Accounts Payable .0 5.4 9.3 5.8 14.1 8.6 9.2 9.8 10.5 11.2
Accounts Payable, % 0.08929399 37.75 43.67 32.32 62.11 35.19 35.19 35.19 35.19 35.19
Capital Expenditure -31.6 -27.8 -6.2 -5.2 -4.0 -13.4 -14.4 -15.4 -16.5 -17.6
Capital Expenditure, % -149.31 -194.94 -29.07 -29.13 -17.78 -55.2 -55.2 -55.2 -55.2 -55.2
Tax Rate, % -0.00509463 -0.00509463 -0.00509463 -0.00509463 -0.00509463 -0.00509463 -0.00509463 -0.00509463 -0.00509463 -0.00509463
EBITAT -7.1 -205.9 -96.9 14.2 -193.3 -12.3 -13.1 -14.0 -15.0 -16.1
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -35.7 -227.4 -94.8 17.3 -185.3 -17.5 -16.4 -17.6 -18.8 -20.1
WACC, % 5.17 5.4 5.46 5.46 5.46 5.39 5.39 5.39 5.39 5.39
PV UFCF
SUM PV UFCF -77.1
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) -21
Terminal Value -605
Present Terminal Value -466
Enterprise Value -543
Net Debt 65
Equity Value -608
Diluted Shares Outstanding, MM 18
Equity Value Per Share -34.12

What You Will Get

  • Real Celularity Data: Preloaded financials – from revenue to EBIT – based on actual and projected figures.
  • Full Customization: Adjust all critical parameters (yellow cells) like WACC, growth %, and tax rates.
  • Instant Valuation Updates: Automatic recalculations to analyze the impact of changes on Celularity’s fair value.
  • Versatile Excel Template: Tailored for quick edits, scenario testing, and detailed projections.
  • Time-Saving and Accurate: Skip building models from scratch while maintaining precision and flexibility.

Key Features

  • Comprehensive Data: Celularity Inc.'s (CELU) detailed financial statements and projected forecasts.
  • Customizable Parameters: Adjust WACC, tax rates, revenue growth, and EBITDA margins to suit your analysis.
  • Real-Time Insights: Instantly view Celularity's (CELU) intrinsic value as it updates dynamically.
  • Informative Visualizations: Interactive dashboard charts illustrate valuation outcomes and essential metrics.
  • Designed for Precision: A reliable tool tailored for analysts, investors, and finance professionals.

How It Works

  1. Step 1: Download the Excel file.
  2. Step 2: Review pre-entered Celularity Inc. (CELU) data (historical and projected).
  3. Step 3: Adjust key assumptions (yellow cells) based on your analysis.
  4. Step 4: View automatic recalculations for Celularity Inc.'s intrinsic value.
  5. Step 5: Use the outputs for investment decisions or reporting.

Why Choose the Celularity Inc. (CELU) Calculator?

  • Precision: Utilizes accurate Celularity financial data for reliable results.
  • Adaptability: Built for users to easily experiment and adjust inputs as needed.
  • Efficiency: Eliminate the complexities of creating a financial model from the ground up.
  • Expert-Level: Crafted with the insight and usability expected by financial professionals.
  • Intuitive: Designed for straightforward navigation, suitable for users without extensive financial modeling skills.

Who Should Use Celularity Inc. (CELU)?

  • Investors: Enhance your portfolio decisions with insights from cutting-edge cellular therapies.
  • Healthcare Analysts: Streamline your research with comprehensive data on innovative treatments.
  • Consultants: Effortlessly modify presentations or reports to showcase the latest developments in cell-based medicine.
  • Biotech Enthusiasts: Expand your knowledge of regenerative medicine through real-world applications and case studies.
  • Educators and Students: Utilize it as a valuable resource in courses focused on biotechnology and healthcare innovation.

What the Template Contains

  • Operating and Balance Sheet Data: Pre-filled Celularity Inc. (CELU) historical data and forecasts, including revenue, EBITDA, EBIT, and capital expenditures.
  • WACC Calculation: A dedicated sheet for Weighted Average Cost of Capital (WACC), including parameters like Beta, risk-free rate, and share price.
  • DCF Valuation (Unlevered and Levered): Editable Discounted Cash Flow models showing intrinsic value with detailed calculations.
  • Financial Statements: Pre-loaded financial statements (annual and quarterly) to support analysis.
  • Key Ratios: Includes profitability, leverage, and efficiency ratios for Celularity Inc. (CELU).
  • Dashboard and Charts: Visual summary of valuation outputs and assumptions to analyze results easily.

No products were found matching.